ArticleCancer medicine2024

LMAN2 Promotes Breast Cancer Tumorigenesis and Drug Resistance by Interacting With MAPK9 via Activation of the MAPK Pathway.

Chen Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.